Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Receivables - Other: 2020-2024

Historic Receivables - Other for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $1.8 million.

  • Caribou Biosciences' Receivables - Other rose 8.62% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 8.62%. This contributed to the annual value of $1.8 million for FY2024, which is 20.03% down from last year.
  • Caribou Biosciences' Receivables - Other amounted to $1.8 million in FY2024, which was down 20.03% from $2.3 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Receivables - Other ranged from a high of $5.5 million in FY2021 and a low of $1.8 million during FY2024.
  • Moreover, its 3-year median value for Receivables - Other was $2.2 million (2022), whereas its average is $2.1 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first spiked by 48.91% in 2021, then tumbled by 59.02% in 2022.
  • Over the past 5 years, Caribou Biosciences' Receivables - Other (Yearly) stood at $3.7 million in 2020, then skyrocketed by 48.91% to $5.5 million in 2021, then slumped by 59.02% to $2.2 million in 2022, then grew by 1.74% to $2.3 million in 2023, then fell by 20.03% to $1.8 million in 2024.